BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 31734230)

  • 1. Next-Generation Sequencing Reveals Potential Predictive Biomarkers and Targets of Therapy for Urothelial Carcinoma in Situ of the Urinary Bladder.
    Garczyk S; Ortiz-Brüchle N; Schneider U; Lurje I; Guricova K; Gaisa NT; Lorsy E; Lindemann-Docter K; Heidenreich A; Knüchel R
    Am J Pathol; 2020 Feb; 190(2):323-332. PubMed ID: 31734230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-generation sequencing of urine specimens: A novel platform for genomic analysis in patients with non-muscle-invasive urothelial carcinoma treated with bacille Calmette-Guérin.
    Scott SN; Ostrovnaya I; Lin CM; Bouvier N; Bochner BH; Iyer G; Solit D; Berger MF; Lin O
    Cancer Cytopathol; 2017 Jun; 125(6):416-426. PubMed ID: 28339163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic profiling of Chinese patients with urothelial carcinoma.
    Yang B; Zhao X; Wan C; Ma X; Niu S; Guo A; Wang J; Wang J; Sun D; Jiao S
    BMC Cancer; 2021 Feb; 21(1):162. PubMed ID: 33588785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiregion human bladder cancer sequencing reveals tumour evolution, bladder cancer phenotypes and implications for targeted therapy.
    Heide T; Maurer A; Eipel M; Knoll K; Geelvink M; Veeck J; Knuechel R; van Essen J; Stoehr R; Hartmann A; Altmueller J; Graham TA; Gaisa NT
    J Pathol; 2019 Jun; 248(2):230-242. PubMed ID: 30719704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.
    Ward DG; Gordon NS; Boucher RH; Pirrie SJ; Baxter L; Ott S; Silcock L; Whalley CM; Stockton JD; Beggs AD; Griffiths M; Abbotts B; Ijakipour H; Latheef FN; Robinson RA; White AJ; James ND; Zeegers MP; Cheng KK; Bryan RT
    BJU Int; 2019 Sep; 124(3):532-544. PubMed ID: 31077629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.
    Sanford T; Meng MV; Railkar R; Agarwal PK; Porten SP
    Clin Epigenetics; 2018; 10():19. PubMed ID: 29456764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing the Genomic Landscape of the Micropapillary Subtype of Urothelial Carcinoma of the Bladder Harboring Activating Extracellular Mutations of ERBB2.
    Posada JM; Yakirevich E; Kamat AM; Sood A; Jacob JM; Bratslavsky G; Grivas P; Spiess PE; Li R; Necchi A; Mega AE; Golijanin DJ; Pavlick D; Huang RSP; Lin D; Danziger N; Sokol ES; Sivakumar S; Ross JS; Cheng L
    Mod Pathol; 2024 Mar; 37(3):100424. PubMed ID: 38219954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomic profiling of glandular bladder tumours.
    Maurer A; Ortiz-Bruechle N; Guricova K; Rose M; Morsch R; Garczyk S; Stöhr R; Bertz S; Golz R; Reis H; Bremmer F; Zimpfer A; Siegert S; Kristiansen G; Schwamborn K; Gassler N; Knuechel R; Gaisa NT;
    Virchows Arch; 2020 Sep; 477(3):445-454. PubMed ID: 32198650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a custom next-generation sequencing panel for the determination of bladder cancer risk in a Tunisian cohort.
    Hemissi I; Boussetta S; Dallali H; Hellal F; Durand G; Voegele C; Ayed H; Zaghbib S; Naimi Z; Ayadi M; Chebil M; Mckay J; Le Calvez-Kelm F; Ouerhani S
    Mol Biol Rep; 2022 Feb; 49(2):1233-1258. PubMed ID: 34854013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker.
    Li WT; Zheng H; Nguyen V; Wang-Rodriguez J; Ongkeko WM
    Neoplasia; 2018 Apr; 20(4):364-373. PubMed ID: 29544183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive molecular characterization of urothelial bladder carcinoma.
    Cancer Genome Atlas Research Network
    Nature; 2014 Mar; 507(7492):315-22. PubMed ID: 24476821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic heterogeneity as a barrier to precision oncology in urothelial cancer.
    Clinton TN; Chen Z; Wise H; Lenis AT; Chavan S; Donoghue MTA; Almassi N; Chu CE; Dason S; Rao P; Rodrigues JA; Vasani NB; Ridouani F; Rosenberg JE; Bajorin DF; Teo MY; Bochner BH; Berger MF; Ostrovnaya I; Pietzak EJ; Iyer G; Gao SP; Hu W; Al-Ahmadie HA; Solit DB
    Cell Rep; 2022 Dec; 41(12):111859. PubMed ID: 36543146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ.
    Yao Z; Xu N; Shang G; Wang H; Tao H; Wang Y; Qin Z; Tan S; Feng J; Zhu J; Ma F; Tian S; Zhang Q; Qu Y; Hou J; Guo J; Zhao J; Hou Y; Ding C
    Nat Commun; 2023 Sep; 14(1):5670. PubMed ID: 37704624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Precision Medicine for Bladder Cancer.
    Guercio BJ; Iyer G; Rosenberg JE
    Hematol Oncol Clin North Am; 2021 Jun; 35(3):633-653. PubMed ID: 33958155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiomics profiling of urothelial carcinoma
    Anurag M; Strandgaard T; Kim SH; Dou Y; Comperat E; Al-Ahmadie H; Inman BA; Taber A; Nordentoft I; Jensen JB; Dyrskjøt L; Lerner SP
    iScience; 2024 Mar; 27(3):109179. PubMed ID: 38439961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer.
    Ericson KJ; Murthy PB; Bryk DJ; Ramkumar RR; Broughman JR; Khanna A; Mian OY; Campbell SC
    Clin Adv Hematol Oncol; 2019 Dec; 17(12):697-707. PubMed ID: 31851158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of potential therapeutic targets in urothelial bladder carcinoma of Chinese population by targeted next-generation sequencing.
    Wang T; Liu Z; Wang X; Bai P; Sun A; Shao Z; Luo R; Wu Z; Zhang K; Li W; Xiao W; Duan B; Wang Y; Chen B; Xing J
    Cancer Biol Ther; 2020 Aug; 21(8):709-716. PubMed ID: 32449441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of UTX/KDM6A Enriches Precursor Cell Populations in Urothelial Cell Cultures and Cell Lines.
    Lang A; Whongsiri P; Yilmaz M; Lautwein T; Petzsch P; Greife A; Günes C; Köhrer K; Niegisch G; Hoffmann M; Schulz WA
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32326336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC).
    Laukhtina E; Mostafaei H; D'Andrea D; Pradere B; Quhal F; Mori K; Miura N; Schuettfort VM; Sari Motlagh R; Aydh A; Abufaraj M; Karakiewicz PI; Enikeev D; Kimura S; Shariat SF
    World J Urol; 2021 Jun; 39(6):1961-1968. PubMed ID: 32808107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-250].
    Witjes JA; Babjuk M; Bellmunt J; Bruins HM; De Reijke TM; De Santis M; Gillessen S; James N; Maclennan S; Palou J; Powles T; Ribal MJ; Shariat SF; Van Der Kwast T; Xylinas E; Agarwal N; Arends T; Bamias A; Birtle A; Black PC; Bochner BH; Bolla M; Boormans JL; Bossi A; Briganti A; Brummelhuis I; Burger M; Castellano D; Cathomas R; Chiti A; Choudhury A; Compérat E; Crabb S; Culine S; De Bari B; De Blok W; De Visschere PJL; Decaestecker K; Dimitropoulos K; Dominguez-Escrig JL; Fanti S; Fonteyne V; Frydenberg M; Futterer JJ; Gakis G; Geavlete B; Gontero P; Grubmüller B; Hafeez S; Hansel DE; Hartmann A; Hayne D; Henry AM; Hernandez V; Herr H; Herrmann K; Hoskin P; Huguet J; Jereczek-Fossa BA; Jones R; Kamat AM; Khoo V; Kiltie AE; Krege S; Ladoire S; Lara PC; Leliveld A; Linares-Espinós E; Løgager V; Lorch A; Loriot Y; Meijer R; Mir MC; Moschini M; Mostafid H; Müller AC; Müller CR; N'Dow J; Necchi A; Neuzillet Y; Oddens JR; Oldenburg J; Osanto S; Oyen WJG; Pacheco-Figueiredo L; Pappot H; Patel MI; Pieters BR; Plass K; Remzi M; Retz M; Richenberg J; Rink M; Roghmann F; Rosenberg JE; Rouprêt M; Rouvière O; Salembier C; Salminen A; Sargos P; Sengupta S; Sherif A; Smeenk RJ; Smits A; Stenzl A; Thalmann GN; Tombal B; Turkbey B; Lauridsen SV; Valdagni R; Van Der Heijden AG; Van Poppel H; Vartolomei MD; Veskimäe E; Vilaseca A; Rivera FAV; Wiegel T; Wiklund P; Willemse PM; Williams A; Zigeuner R; Horwich A
    Eur Urol; 2020 Jul; 78(1):e48-e50. PubMed ID: 32446863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.